Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-25

Clinical Trial Update: Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis [NA]

View source ↗

Summary

A small randomized pilot study compared paromomycin (aminosidine) to streptomycin for uncomplicated pulmonary tuberculosis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paromomycin (paromomycin)
  • Streptomycin (Streptomycin)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Tuberculosis, Pulmonary | NA | Status: COMPLETED